Literature DB >> 16221384

How to establish a high-risk cancer genetics clinic: limitations and successes.

Mary B Daly1, Beth Stearman, Agnes Masny, Elaine Sein, Susan Mazzoni.   

Abstract

The development of technology to locate and isolate cancer susceptibility genes has brought together the fields of oncology, cancer control, genetics, and genetic counseling to create a new specialty of cancer risk counseling with the goal to communicate more accurate information about personal cancer risk profiles based on personal and family histories. As cancer risk assessment and counseling services become standard of care in medical practice, their availability is increasingly moving from comprehensive cancer centers and academic institutions to community settings. High-risk cancer genetics clinics in the community face several challenges, including staffing, time commitment, costs, and unique quality control issues. The societal benefits include a more educated public armed with the information needed to make health decisions appropriate for the individual level of risk.

Entities:  

Mesh:

Year:  2005        PMID: 16221384     DOI: 10.1007/s11912-005-0012-2

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  20 in total

1.  "Genetic exceptionalism" in medicine: clarifying the differences between genetic and nongenetic tests.

Authors:  Michael J Green; Jeffrey R Botkin
Journal:  Ann Intern Med       Date:  2003-04-01       Impact factor: 25.391

2.  Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.

Authors:  W F Lawrence; B N Peshkin; W Liang; C Isaacs; C Lerman; J S Mandelblatt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-05       Impact factor: 4.254

3.  BRCA1 Testing: Genetic Counseling Protocol Development and Counseling Issues.

Authors:  B J Baty; V L Venne; J McDonald; R T Croyle; C Halls; J E Nash; J R Botkin
Journal:  J Genet Couns       Date:  1997-06       Impact factor: 2.537

4.  Physicians' knowledge of genetics and genetic tests.

Authors:  K J Hofman; E S Tambor; G A Chase; G Geller; R R Faden; N A Holtzman
Journal:  Acad Med       Date:  1993-08       Impact factor: 6.893

5.  Identification and referral of families at high risk for cancer susceptibility.

Authors:  Kevin M Sweet; Terry L Bradley; Judith A Westman
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

6.  Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.

Authors:  L Wideroff; S T Vadaparampil; M H Greene; S Taplin; L Olson; A N Freedman
Journal:  J Med Genet       Date:  2005-03-22       Impact factor: 6.318

Review 7.  Costs and benefits of diagnosing familial breast cancer.

Authors:  P Møller
Journal:  Ann Oncol       Date:  2004       Impact factor: 32.976

8.  Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.

Authors:  Michael J Green; Susan K Peterson; Maria Wagner Baker; Gregory R Harper; Lois C Friedman; Wendy S Rubinstein; David T Mauger
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

9.  Interest in BRCA1/2 testing in a primary care population.

Authors:  Katrina Armstrong; Barbara Weber; Peter A Ubel; Carmen Guerra; J Sanford Schwartz
Journal:  Prev Med       Date:  2002-06       Impact factor: 4.018

10.  What motivates interest in attending a familial cancer genetics clinic?

Authors:  L Fraser; S Bramald; C Chapman; C Chu; V Cornelius; F Douglas; A Lucassen; A Nehammer; S Sutton; M Trivella; S Hodgson
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.446

View more
  2 in total

1.  Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Authors:  Patricia Ashton-Prolla; Juliana Giacomazzi; Aishameriane V Schmidt; Fernanda L Roth; Edenir I Palmero; Luciane Kalakun; Ernestina S Aguiar; Susana M Moreira; Erica Batassini; Vanessa Belo-Reyes; Lavinia Schuler-Faccini; Roberto Giugliani; Maira Caleffi; Suzi Alves Camey
Journal:  BMC Cancer       Date:  2009-08-14       Impact factor: 4.430

2.  Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews.

Authors:  Jennifer L Schneider; Katrina A B Goddard; Kristin R Muessig; James V Davis; Alan F Rope; Jessica E Hunter; Susan K Peterson; Louise S Acheson; Sapna Syngal; Georgia L Wiesner; Jacob A Reiss
Journal:  Hered Cancer Clin Pract       Date:  2018-05-10       Impact factor: 2.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.